Human and nonclinical disposition of [<sup>14</sup>C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection
Raju Subramanian(Gilead Sciences (United States)), Bill J. Smith(Gilead Sciences (United States)), Samantha Wijaya(Gilead Sciences (United States)), Heather Zhang(Gilead Sciences (United States)), Yurong Lai(Pfizer (United States)), Jianhong Wang(Gilead Sciences (United States)), John Ling(Gilead Sciences (United States)), Haolun Jin(Gilead Sciences (United States)), Kelly Wang(Gilead Sciences (United States)), Bernard P. Murray(Gilead Sciences (United States)), Jia Hao(Gilead Sciences (United States))
Cited by 7
Related Papers
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity
|Clinical Pharmacology & Therapeutics|2009|208
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
|Journal of Mass Spectrometry|2006|153